The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.
 
Carlo Guerrero
No Relationships to Disclose
 
Joe E. Ensor
Consulting or Advisory Role - StatAnalytics IDD
 
Kai Sun
No Relationships to Disclose
 
Andrew M. Farach
No Relationships to Disclose
 
Sindhu Nair
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose
 
Monisha Singh
No Relationships to Disclose
 
Jorge German Darcourt
No Relationships to Disclose
 
Priya V. Ramshesh
No Relationships to Disclose
 
Edward Brian Butler
No Relationships to Disclose
 
Bin S. Teh
No Relationships to Disclose
 
Mark Sultenfuss
No Relationships to Disclose
 
Nakul Gupta
Speakers' Bureau - GE Healthcare
Research Funding - Siemens Healthineers
Travel, Accommodations, Expenses - GE Healthcare; Siemens Healthineers
 
Helen E. Heslop
Stock and Other Ownership Interests - Allovir; Fresh Wind Biotechnologies; Marker Therapeutics
Consulting or Advisory Role - Gilead Sciences; Kiadis Pharma; Marker Therapeutics; Mesoblast; Novartis; PACT Pharma; Tessa Therapeutics
Research Funding - Cell Medica (Inst); Tessa Therapeutics (Inst)
 
Jaime A. Mejia
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
 
Jenny Chee Ning Chang
Consulting or Advisory Role - Celgene; Genentech
Travel, Accommodations, Expenses - Celgene; Genentech
 
Eric Bernicker
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Novartis; Pfizer
Speakers' Bureau - Blueprint Medicines
Research Funding - EMD Serono